These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29873156)

  • 41. Humans Are Selectively Exposed to Pneumocystis jirovecii.
    Cissé OH; Ma L; Jiang C; Snyder M; Kovacs JA
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current epidemiology of Pneumocystis jirovecii infections].
    Gołab E
    Przegl Epidemiol; 2009; 63(3):353-7. PubMed ID: 19899590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.
    Mori S; Sugimoto M
    Rheumatology (Oxford); 2012 Dec; 51(12):2120-30. PubMed ID: 23001613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Should patients with malignancy receive chemoprophylaxis against Pneumocystis jirovecii pneumonia?
    Barbounis V
    Nat Clin Pract Oncol; 2005 Oct; 2(10):490-1. PubMed ID: 16205763
    [No Abstract]   [Full Text] [Related]  

  • 45. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases.
    Ghembaza A; Vautier M; Cacoub P; Pourcher V; Saadoun D
    Chest; 2020 Dec; 158(6):2323-2332. PubMed ID: 32502592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients-authors' response.
    Cordonnier C; Alanio A; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Maertens J; ;
    J Antimicrob Chemother; 2017 Apr; 72(4):1266-1268. PubMed ID: 28122911
    [No Abstract]   [Full Text] [Related]  

  • 47. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of positive
    Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
    Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cluster of Pneumocystis jirovecii infection among outpatients with rheumatoid arthritis.
    Mori S; Cho I; Sugimoto M
    J Rheumatol; 2010 Jul; 37(7):1547-8. PubMed ID: 20595296
    [No Abstract]   [Full Text] [Related]  

  • 50. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
    Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
    J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-lasting cluster of nosocomial pneumonia with a single Pneumocystis jirovecii genotype involving different organ allograft recipients.
    Hosseini-Moghaddam SM; Dufresne PJ; Hunter Gutierrez E; Dufresne SF; House AA; Humar A; Kumar D; Jevnikar AM
    Clin Transplant; 2020 Dec; 34(12):e14108. PubMed ID: 33048378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pneumocystis jirovecii Pneumonia.
    Catherinot E; Lanternier F; Bougnoux ME; Lecuit M; Couderc LJ; Lortholary O
    Infect Dis Clin North Am; 2010 Mar; 24(1):107-38. PubMed ID: 20171548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
    Cordonnier C; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Alanio A; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Maertens J;
    J Antimicrob Chemother; 2016 Sep; 71(9):2379-85. PubMed ID: 27550990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients.
    Veronese G; Ammirati E; Moioli MC; Baldan R; Orcese CA; De Rezende G; Veronese S; Masciocco G; Perna E; Travi G; Puoti M; Cipriani M; Tiberi S; Cirillo D; Frigerio M
    Transpl Infect Dis; 2018 Jun; 20(3):e12880. PubMed ID: 29514393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit.
    Desoubeaux G; Dominique M; Morio F; Thepault RA; Franck-Martel C; Tellier AC; Ferrandière M; Hennequin C; Bernard L; Salamé E; Bailly É; Chandenier J
    J Clin Microbiol; 2016 May; 54(5):1314-20. PubMed ID: 26935726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia.
    Lanaspa M; O'Callaghan-Gordo C; Machevo S; Madrid L; Nhampossa T; Acácio S; de la Horra C; Friaza V; Campano E; Alonso PL; Calderón EJ; Roca A; Bassat Q
    Clin Microbiol Infect; 2015 Nov; 21(11):1018.e9-1018.e15. PubMed ID: 26231980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.
    Tasaka S; Tokuda H
    J Infect Chemother; 2012 Dec; 18(6):793-806. PubMed ID: 22864454
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current issues in the epidemiology, transmission, and reactivation of Pneumocystis carinii.
    Hughes WT
    Semin Respir Infect; 1998 Dec; 13(4):283-8. PubMed ID: 9872624
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pneumocystis polymerase chain reaction and blood (1→3)-β-D-glucan assays to predict survival with suspected Pneumocystis jirovecii pneumonia.
    Matsumura Y; Ito Y; Yamamoto M; Matsushima A; Nagao M; Takakura S; Iinuma Y; Ichiyama S
    J Infect Chemother; 2014 Feb; 20(2):109-14. PubMed ID: 24480550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.